natgillin/translations-raw huggingface dataset:
The pharmaceutical composition as defined in claim 3 for use according to claim 9, wherein the antibiotic-resistant bacteria is resistant to vancomycin, methicillin, glycopeptide antibiotics, penicillin or daptomycin. 
Farmaceutski pripravak u skladu s patentnim zahtjevom 3, namijenjen upotrebi u skladu s patentnim zahtjevom 9, naznačen time što su bakterije otporne na antibiotike otporne na vankomicin, meticilin, glikopeptidne antibiotike, penicilin ili daptomicin.
wherein c represents an integer of 1 to 3, and Z1 represents oxygen, sulfur, carbonyl, sulfonyl or a group represented by the formula —NRZ1—, wherein RZ1 represents hydrogen or C1-6 alkyl, and R11d may be substituted with a substituent selected from Substituent Group A or Substituent Group B recited in [1]. 
Z pri čemu c predstavlja cijeli broj od 1 do 3, te Z! predstavlja kisik, sumpor, karbonil, sulfonil ili skupinu prikazanu sa formulom -NR"'-, pri čemu R"' predstavlja vodik ili C,.g alkil, i R!'"* može biti supstituiran sa supstituentom odabranim iz supstitucijske skupine A ili supstitucijske skupine B kako je navedeno u zahtjevu 1.
blending the sized granules from step (3) and the extragranular disintegrant in a suitable blender; 
miješanja granula dobivenih u koraku (4) i ekstragranularnog sredstva za raspadanje u miješalici;
The compound according to claim 1 wherein R-A is selected from 
Spoj prema patentnom zahtjevu 1 naznačen time što R-A je izabran od oo
Compounds of the present invention inhibit the Fc epsilon induced degranulation responses, including the basophil cell line, RBL. 
Spojevi prikazanog izuma inhibirati će degranulacijske odgovore inducirane Fc epsilonom, uključujući bazofilnu staničnu liniju, RBL.
The rotary machine according to claim 1, wherein the radially extending flange portions on radially extending surfaces have a fine clearance relative to an internal end surface of the respective end covers. 
Rotacijski motor prema bilo kojem patentnom zahtjevu od 1 do 4, naznačen time da radijalno rastezni dijelovi prirubnice (2a', 2b') na svojoj radijalnoj površini imaju precizno odstupanje u odnosu na unutarnju krajnju površinu odgovarajućih završnih pokrova (5a, 5b)
The material according to claims 1-4 wherein the mesh size is 0.01 to 0.80 mm, especially preferred from 0.04 to 0.25 mm. 
Materijal temeljem bilo kojeg zahtjeva od 1 do 4 naznačen time što je veličina otvora staklenog vlakna od 0,01 do 0,80 mm, posebno povoljno od 0,04 do 0,25 mm.
A compound of claim 1 which is N-methyl-1-{trans-4-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclohexyl}methanesulfonamide, or a pharmaceutically acceptable salt thereof. 
Spoj u skladu s patentnim zahtjevom 1, naznačen time što je N-metil-1-(trans-4-[metil(7H-pirolo[2,3-d]pirimidin-4-il)aminojcikloheksilt metansulfonamid, ili njegova farmaceutski prihvatljiva sol.
System and method for communicating credentials 
SUSTAV I POSTUPAK SLANJA VJERODAJNICA
The powders and tablets may contain varying percentage amounts of the active compound. 
Prašci i tablete mogu sadržavati različite postotke aktivnog spoja.
reacting a compound of formula I wherein R is hydrogen, with tritium gas in the presence of a iridium, ruthenium, rhodium or palladium catalyst in a suitable solvent, selected from dichloromethane, chlorobenzene, DMF, DMSO or mixtures thereof to afford compound of formula I wherein R is tritium, and, if desired, converting the compounds obtained into pharmaceutically acceptable acid addition salts or dissolving a compound of formula 10 in dimethylsulfoxide and sonicate prior to end of bombardment with aqueous [18]fluoride ion to a compound of formula and, if desired, converting the compounds obtained into pharmaceutically acceptable acid addition salts. 
S tricijevim plinom u prisutnosti katalizatora iridija, rutenija, rodija ili paladija, u prikladnom otapalu koje je odabrano između diklorometana, klorobenzena, dimetilfurana, dimetilsulfoksida ili njihovih smjesa, kako bi se stvorio spoj formule I gdje je R tricij, te ako je poželjno, pretvaranje dobivenih spojeva u farmaceutski prihvatljive kiselinske adicijske soli, ili otapanje spoja formule 10 u dimetilsulfoksidu i podvrgavanje sonikaciji prije kraja bombardiranja s vodenim [1$]fluoridnim ionom za spoj formule te ako je poželjno, pretvaranje dobivenih spojeva u farmaceutski prihvatljive kiselinske adicijske soli.
The pharmaceutical composition according to claim 13, formulated for oral administration. 
Farmaceutski sastav prema zahtjevu 20 ili 21, formuliran za oralnu primjenu.
The 1-thio-D-glucitol compound, or the pharmaceutically acceptable salt thereof, or the hydrate of the compound or the salt according to claim 1 or 2, wherein Ar1 is an arylene group. 
Spoj 1-tio-D-glucitol, ili njegova farmaceutski prihvatljiva sol, ili hidrat spoja ili njegova sol prema zahtjevu 1 ili 2, naznačen time da Ar je heteroarilen skupina.
The capacity of the apparatus for treatment with superheated steam is several thousands of kilograms per hour. The invention involves a method for producing fertilizer out of sludge, in which method sludge is heated with superheated steam to achieve hygienization to destroy pathogenic organisms. In the method, the sludge is heated to a temperature of 60 to 100° C. with superheated steam having a temperature of 200 to 600° C. to activate increasing of the amount of soluble carbon in the sludge and to restart biodegradation of the sludge by using non-pathogenic microorganisms still remaining in the sludge after the heating. 
Metoda za proizvodnju gnojiva iz mulja, u ovoj se metodi mulj zagrijava superzagrijanom parom zbog postizanja higijenizacije u svrhu uništavanja patogenih mikroorganizama, karakterizirana zagrijavanjem mulja do temperature 60 do 100*C superzagrijanom parom, koja je plinovita smjesa vodene pare i plina izgaranja goriva, superzagrijana para ima temperaturu od 200 do 600"C kako bi aktivirala povećanje količine topljivog ugljika u mulju i kako bi ponovo pokrenula biorazgradnju mulja koristeći nepatogene mikroorganizme još preostale u mulju nakon zagrijavanja, tretiranje superzagrijanom parom se izvodi pri normalnom atmosferskom tlaku u beztlačnoj jedinici za tretiranje parom i tretiranje superzagrijanom parom se izvodi kao kontinuirani postupak umjesto zatvorenog serijskog postupka.
wherein R1, R2 and R3 have the meanings as described under formula I; 
R, pri čemu R,, R2 i R3 imaju značenja kao što je opisano pod formulom I;
The extraction module comprises first jaw member and a cooperating second jaw member. 
Ovaj modul za ekstrakciju ima prvi element čeljusti i drugi element čeljusti koji je povezan u radu s prvim elementom čeljusti.
Process according to claim 9, characterized in that the submerged condenser is of the shell and tube type and that the high pressure fluids are on the shell side. 
Postupak sukladno zahtjevu 7, naznačen time što je uronjeni kondenzator tipa sa cjevnim omotačem i cjevima i da su tekućine pod visokom tlakom na strani cjevnog omotača.
In an embodiment, trehalose is present at a concentration of 200 mM. 
* - jebezarginina ili sadrži arginin u koncentraciji od najviše 0.1 mM;
In one embodiment the vaccine strain quantified by the kit of parts is the CVI988 vaccine. 
Komplet u skladu s patentnim zahtjevima 16-19, naznačen time što je cjepivni soj cjepivo CVI988.
Fig. 2 shows two packaging 2 comprising a first side 4, a second side 6 and a hinging part 8. 
Slika 2 prikazuje dva pakiranja 2 koja imaju prvu stranu 4, drugu stranu 6 i zglobni dio 8.
The crystalline Form A of claim 1, wherein the crystalline form exhibits an X-Ray powder diffraction (XRPD) pattern substantially the same as shown in FIG. 1 . 
Kristalni oblik prema bilo kojem od zahtjeva 1-3, naznačen time da navedeni kristalni oblik ima spektar difrakcije X-zraka praha (XRPD) isti kao što je prikazan na Slici 2.
The second embodiment of the first aspect of the method comprises the step of: 
(32) Datum podnošenja prve prijave: 26.08.2011.
Use of E 89, wherein the susceptibility diagnosis is based on the patient having a systemic autoimmune disease. 
Uporaba u skladu sa zahtjevom 89, naznačena time, da je dijagnoza osjetljivosti zasnovana na tome da pacijent ima sistemsku autoimunu bolest.
said key blade having at least one longitudinally extending code pattern with a number of code recesses for engagement with a respective key sensing part of said locking tumblers of said associated cylinder lock, 
- < navedeni krak ključa ima barem jedan uzdužni kodni uzorak sa većim brojem kodnih udubljenja koja surađuju sa odgovarajućim dijelom za raspoznavanje ključa navedenih čepića za zaključavanje navedene odgovarajuće cilindar brave,
The formulation of claim 5, for use in treating a disease or disorder in a human subject, wherein the solid formulation is dissolved in a suitable medium or solvent to become a liquid formulation prior to administration. 
6. - Formulacija u skladu s patentnim zahtjevom 5, naznačena time što je namijenjena upotrebi u liječenju bolesti ili poremećaja kod ljudskog subjekta, gdje se čvrstu formulaciju otopi u pogodnom mediju ili otapalu kako bi se dobilo tekuću formulaciju prije primjene.
The impregnated granules were inserted into the foil tube and rested against the foil disk on the end of the fuel source. 
Impregnirane granule se umetnu u cijev sa folijom 1 naslone se naspram diska od folije na kraju izvora goriva.
µL PGD2 to determine non-specific binding 
25 uL PGD, za određivanje nespecifičnog vezanja,
The high protein, fruit-flavoured beverage according to claim 1, wherein the denatured whey protein composition is: 
Visokoproteinski napitak s voćnom aromom u skladu s patentnim zahtjevom 1, naznačen time što je pripravak denaturiranog proteina sirutke:
a gas discharge tube (GDT) captured and electrically connected between the varistor member and one of the first and second electrodes; and 
gdje je metalno kućište prvog SPD-a električno povezano s PE terminalom preko metalnog kućišta drugog SPD-a.
“C1-4alkyl” means a straight chain or branched, noncyclic or cyclic hydrocarbon containing from 1 to 4 carbon atoms. 
"C,aalkil" znači nerazgranati ili razgranati, neciklički ili ciklički ugljikovodik s 1 do 4 atoma ugljika.
The vector is preferentially use to transform host cell, preferably wherein the host cell is a recombinant human cell already able to express the human long pentraxin PTX3 protein, more preferably wherein the recombinant human cell is the recombinant 293F/PTX3/2F12 clone deposited at ECACC with no. 08011001. In a particular aspect the vector is linearized. It is another object of the invention a recombinant cell able to express the human long pentraxin PTX3 protein encoded by the vector as above disclosed, preferably it is recombinant HEK293F cell line, more preferably it is the recombinant MS24PTX clone deposited at Health Protection Agency, Culture Collections Centre For Emergency Preparedness and Response Salisbury UK, with no. 09072902. 
Transformirana rekombinantna ljudska stanica koja može eksprimirati ljudski dugi protein pentraksin PTX3 koja je rekombinantni 293F/PTX3/2F12 klon, deponiran kod ECACC pod br. 08011001, naznačena time što je dodatno transformirana uz pomoć vektora u skladu s patentnim zahtjevom 1. Transformirana rekombinantna ljudska stanica u skladu s patentnim zahtjevom 3, naznačena time što je rekombinantni MS24PTX klon, deponiran kod Health Protection Agency, Culture Collections Centre For Emergency Preparedness and Response Salisbury UK, pod br. 09072902.
is selected from the group consisting of substituted or unsubstituted aryl, and 
je supstituiran ili nesupstituiran aril, pri čemu je aril odabran od fenila ili naftila; i
A drug-delivery device comprising: a body comprising a matrix of a silicone and an ophthalmic drug, the body having an outer surface and being configured to be inserted through a punctal aperture and positioned in a punctum or lacrimal canaliculus; 
tijelo, koje sadrži silikonski matriks i oftalmički lijek, gdje tijelo ima vanjsku površinu i tako je oblikovano da se može umetnuti kroz punktalni otvor i staviti u punktum (ulaz u suzni kanalić) ili suzni kanalić;
A precipitation stable aqueous composition consisting essentially of from about 0.4% w/v to less than about 2% w/v of a salt of deoxycholic acid and a pharmaceutically acceptable excipient, wherein said composition is maintained at a pH of about 8.1 to about 8.5. 
Taložno stabilan vodeni farmaceutski pripravak, naznačen time što se uglavnom sastoji od 0,4% tež./vol. Do 1% tež./vol. soli deoksikolne kiseline i farmaceutski prihvatljive pomoćne tvari, te što se pH navedenog pripravka održava na 8,2 do 8,5.
A system of any of clauses 23 to 33 which further includes a sensor device arranged outside the successive phase contact devices for determining a parameter of the solid phase as it moves along the pathway. 
(b) senzorski uređaj (558) raspoređen izvan sukcesivnih faznokontaktnih uređaja za određivanje parametra čvrste faze dok se pomjera duž putanje.
A ball launcher according to claim 13 or claim 14, further comprising a control system (5) for controlling the direction of rotation of the rotatable elements, and selecting the speeds of rotation of the rotatable elements. 
Lanser kuglice u skladu s patentnim zahtjevom 13 ili patentnim zahtjevom 14, naznačen time što dodatno ima upravljački sustav (5), namijenjen upravljanju smjerom vrtnje zakretljivih elemenata, te biranju brzina vrtnje zakretljivih elemenata.
The process of the invention allows to get purified unsaturated compounds by simply contacting them with silicon and/or aluminium derivatives, without the need of any further manipulation to increase neither the concentration nor the purity of the unsaturated compounds, likely because of the high binding capacity of the polar by-products of the process, of the products of polymerization and of the other impurities/pollutants with the above mentioned silicon and/or aluminium derivatives. 
Postupak iz izuma ne zahtijeva nikakvu daljnju manipulaciju za povećavanje ni koncentracije ni čistoće nezasićenih spojeva, vjerojatno zbog visokog kapaciteta vezanja polarnih nusprodukata postupka, polimerizacijskih produkata 1 drugih onečišćenja/zagađivača s gore spomenutim derivatima silicija.
Use according to any one of the preceding claims, characterized in that said the at least one polyethylenimine is added to said suspension in an amount of from 500 to 15000 mg, preferably of from 1000 to 5000 mg, and more preferably of 1300 to 4000 mg, per liter of the aqueous phase of said suspension. 
Uporaba prema bilo kojem od prethodnih zahtjeva, naznačena time da navedeni barem jedan polietilenimin je dodan u navedenu suspenziju u količini od 1000 do 5000 mg, te još poželjnije od 1300 do 4000 mg po litri vodene faze navedene suspenzije.
wherein the Caspase is a mammalian, murine or human Caspase, selected from the group consisting of Caspase-2, Caspase-3, Caspase-6, Caspase-7, Caspase-8, Caspase-9, Caspase-10, Caspase-12, most preferably Caspase-8 or Caspase-9; and/or 
gdje je kaspaza od sisavaca, kaspaza od glodavaca ili humana kaspaza, izabrana iz grupe koja obuhvaća Kaspazu-2, Kaspazu-3, Kaspazu-6, Kaspazu-7, Kaspazu-8, Kaspazu-9, Kaspazu-10, Kaspazu-12, najpoželjnije Kaspazu-8 ili Kaspazu-9; i/ili
Examples of such transplants include, but are not limited thereto: kidney, liver, heart, lung, intestine, hematopoietic and bone marrow, skin, limbs, cornea, pancreas, stem cells and cell therapy, grafts or biomaterials, etc. 
Uporaba prema zahtjevu 1, gdje se navedeni transplantat odabire iz bubrega, jetre, srca, crijeva, hematopoetske i leđne moždine, kože, uda, rožnice, gušterače, matične stanice i stanične terapije, i presadaka ili bioloških materijala.
In FIG. 2 the expansion means 10 is shown in the form of an expansion nipple, but in other embodiments the expansion means 10 may for example be a simple, straight tube or a hollow cable. 
Na Slici 2, prikazano je ekspanziono sredstvo 10 u obliku ekspanzionog zavrtnja za povezivanje, ali u drugim izvedbama ekspanziono sredstvo 10 može na primjer biti jednostavna ravna cijev ili šuplji kabel.
a second time deinterleaver (r710) configured to time deinterleave the frequency-deinterleaved constellation values; 
dio za raspletanje vremena (r710) konfiguriran za raspletanje vremena konstelacijskih vrijednosti raspletenih frekvencija;
Likewise, a “glyphosate resistance” or “glyphosate tolerance” polypeptide of the invention is a polypeptide having the amino acid sequence set forth in SEQ ID NO:9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, or 35, and fragments and variants thereof, that confer glyphosate resistance or tolerance to a host cell. 
HR P20110587 TI PATENTNI ZAHTJEVI Molekula nukleinske kiseline, naznačena time, da je odabrana iz skupine koju čine: a) molekula nukleinske kiseline koja sadrži nukleotidni odsječak SEQID NO: 28, 30, 32 ili 34; i, b) molekula nukleinske kiseline koja kodira polipeptid koji sadrži aminokiselinski odsječak SEQ ID NO: 29, 31, 33 ili 35.
After 30 min, compound 3 was added and the reaction was heated to reflux for 5h. 
Nakon 30 min. doda se spoj 3i reakcija se zagrijava uz povrat tijekom 5 h.
The Dynamin 2 inhibitor is selected from the group consisting of an antibody directed against Dynamin 2, a nucleic acid molecule interacting directly a nucleic acid encoding Dynamin 2 expression, and a small molecule inhibiting the Dynamin 2 enzymatic activity (i.e., inhibition of the GTPase activity), expression (such as by inhibiting promoter, splicing or translation), or function (such as inhibition of oligomerisation, activation, lipid binding, or partner binding). 
PATENTNI ZAHTJEVI Inhibitor dinamina 2, namijenjen upotrebi u liječenje centronuklearne miopatije, naznačen time što se inhibitor dinamina 2 bira iz skupine koju čine protutijelo usmjereno protiv dinamina 2, molekula nukleinske kiseline koja izravno međudjeluje s nukleinskom kiselinom koja kodira dinamin 2, te mala molekula koja inhibira aktivnost dinamina 2, njegovo eksprimiranje ili funkciju, gdje se navedenu malu molekulu bira iz skupine koju čine (3,4dihidroksibenziliden)hidrazid
The partition wall element as claimed in claim 1, wherein the wall element has a switching element which is coupled to an alarm device. 
Element pregradne stijenke sukladno bilo kojem od patentnih zahtjeva 1 do 8, naznačen time, što element (4) stijenke ima prekidački element (11) koji je povezan s alarmnim uređajem.
sulbactam sodium in an amount of 1 g, calculated as sulbactam free acid, and 
(b) sulbaktam natrij u količini od 1 g, preračunato kao sulbaktamska slobodna kiselina, i
Also, the crushing processing portion 600 is formed to cover the entire bottom region of the input portion 410 at the height of the crushing processing portion 600 connected to the bottom end of the input portion 410 . 
Modul za ekstrakciju soka u skladu s patentnim zahtjevom 8, naznačen time što dio za obradu drobljenjem (600) pokriva cijelo donje područje dijela za ubacivanje (410) u visini dijela za obradu drobljenjem (600) povezanog s donjim krajem dijela za ubacivanje (410).
is hydrogen, or C1-C6 alkyl optionally substituted by hydroxy; 
R1 je vodik, ili C;-Cg alkil prema potrebi supstituiran s hidroksi;
The process according to Claim 1 wherein Compound H is reacted with Cbz-L-alanine in the presence of THF or ethyl acetate and a coupling agent at -5 to 5°C to afford Compound J, which is then deprotected to afford Compound I. 
Postupak prema zahtjevu 1 gdje Spoj H reagira s Cbz-L-alaninom u prisutnosti THF-a ili etil acetata i sredstva za vezanje na -5 do 5°C da se dobije Spoj J, s kojeg se zatim uklanja zaštita da se dobije Spoj I.
The injector device of claim 21, wherein the injector device produces an audible sound at completion of the dispensation step. 
Naprava za ubrizgavanje iz patentnog zahtjeva 21, pri čemu naprava za ubrizgavanje stvara zvučni signal pri završetku koraka dispenziranja.
obtaining an acrylic acid - acrylonitrile copolymer; 
dobivanje akrilne kiseline-akrilo-nitrilnog kopolimera;
Spraying speed of the pelletizing liquid was set at 50 ml/min, pressure of spraying air was 2.5 bar. 
Brzina raspršivanja tekućine za granuliranje bila je 50 ml/min, a tlak raspršivanja bio je 2,5 bar.
producing an active ingredient trituration wherein the active ingredient is pramipexole or a pharmaceutically acceptable salt thereof by preblending it with a portion of water swelling polymer(s) and/or further excipient(s) in a mixer, wherein pramipexole or the pharmaceutically acceptable salt thereof is milled, preferably peg-milled, prior to use; 
(1) pripravu triturata aktivnog sastojka pri čemu je aktivni sastojak pramipeksol ili njegova farmaceutski više pomoćnog sredstva u mjošalici, pri čemu su pramipeksol ili njegova farmaceutski prihvatljiva sol mljeveni, povoljno je mljeveni u klinastom mlinu prije uporabe;
This arrangement advantageously solves the problem, known in the prior art, of high strength wirelines permitting use of loadings that cause premature separation of the jar mandrel and latch sub components of conventional jars. 
Ovakvo rješenje pogodno rješava problem, poznat prema postojećem stanju tehnike, jako otpornih žicanih veza dozvoljavajući korištenje opterećenja koje izaziva prijevremeno razdvajanje vretena udaraca i elementa zasuna komponenti uobičajenih udaraca.
The decoration may cover all or a part of the packaging. 
Dekoracija može prekriti cijelo pakiranje ili samo njegov jedan dio.
A packaging according to claim 1, wherein the first and second outer parts together cover entire surface of each of the sides of the inner part, respectively. 
Pakiranje u skladu s bilo kojim od prethodnih patentnih zahtjeva, naznačeno time, što prvi i drugi dio zajedno prekriva cijelu vanjsku površinu strana unutarnjeg dijela.
The glidant is selected from the group comprising colloidal silicon dioxide, talc and corn starch, and mixtures thereof. 
Uglađivač se bira iz skupine koja se sastoji iz koloidnog silikonskog dioksida, talka i kukuruznog škroba, 1 njihovih mješavina.
A plant according to claim 2, wherein the pressure controlling mechanism comprises a pump and a valve, the valve controlling the pressure in coolant from the pump through the heat exchanger and NG/coolant heat exchanger above the boiling pressure. 
Postrojenje prema bilo kojem od prethodnih zahtjeva, naznačeno time što zatvoreni krug rashladnog sredstva sadrži ventil (F), pri čemu ventil (F) kontrolira tlak u isparenom rashladnom sredstvu.
The amine used was ethylamine. 
Korišteni amin bio je etilamin.
The additive composition according to one or more of the previous claims, wherein the pH of the composition is lower than 6, preferably lower than 5, even more preferably lower than 3.5. 
Kompozicija aditiva prema jednom ili više prethodnih patentnih zahtjeva, gdje je pH kompozicije niža od 5, poželjnije niža od 3.5.
In some embodiments, the solid form is characterized by all of the peaks. In some embodiments, provided herein is a solid form comprising a HCl salt of Compound (I-S) having an XRPD pattern comprising peaks at approximately 15.09, 15.94, and 22.30 degrees 2θ. 
Čvrsti oblik HCI soli spoja (I-S): OJ (1-5), naznačen time što je čvrsti oblik kristalni oblik Oblika A s karakterističnim XRPD uzorkom koji ima vrhove na približno 15.09, 15.94 i 22.30 stupnjeva 20.
A process according to claim 5 or 6, wherein the composition has an operating characteristic of superheat during refrigeration of at least 2°F. 
Postupak prema bilo kojem prethodnom zahtjevu, naznačen time da rashladna tvar ima radnu karakteristiku pregrijavanja tijekom hlađenja od barem 1.1°C (2°F).